Neuroendocrine and Receptor Research

Neuroendocrine and receptor research covers peptides studied at the interface between nervous-system signaling and endocrine regulation, where a single sequence may act on centrally expressed receptors to influence downstream hormonal cascades. Compounds in this category include PT-141, a cyclic heptapeptide melanocortin receptor agonist studied primarily for its binding profile at the centrally expressed MC3R and MC4R subtypes rather than the peripheral MC1R pathway. Cyclic peptides present specific analytical considerations: ring closure must be confirmed rather than assumed, since a linear impurity of identical mass will not separate on molecular weight alone. Identity confirmation for compounds in this category therefore relies on combined HPLC retention behavior and mass-spectrometric analysis, both documented on the batch COA. All products in this category are supplied strictly for laboratory research use. They are not drugs, not dietary supplements, and are not for human or veterinary use.